Work

Abstract P4-13-26: Efficacy, safety, and treatment decision-making in the AVANTI German observational study of first-line bevacizumab (BEV)-containing therapy for locally advanced, recurrent, or metastatic breast cancer (aBC)

Year: 2016

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.sabcs15-p4-13-26

Authors: V Müller, A Jakob, B Aktas, A Grafe, W Fett, W März, H Bruch, D Pott, P Klare, E Boller, C Kiewitz, A Schneeweiss

Institutions: Paracelsus-Kliniken, University Medical Center Hamburg-Eppendorf, Essen University Hospital, Südharz Klinikum

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2396544020

Cites:

Cited by: 1

Related to: 10